- Filed
- May 20, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · May 20, 2024 | 156.64M sh |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $845.2K |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $874.66K |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $2.12M |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $2.15M |
| Current Assets | Q1 2024 · Mar 31, 2024 | $732.24K |
| Current Assets | Q1 2024 · Dec 31, 2023 | $918.03K |
| Total Assets | Q1 2024 · Mar 31, 2024 | $4.78M |
| Total Assets | Q1 2024 · Dec 31, 2023 | $4.85M |
| Shares Diluted restated | Q1 2024 · Mar 31, 2023 | 153.65M sh |
| Capex | Q1 2024 · Mar 31, 2023 | $131.41K |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | $166.5K |
| Stockholders Equity | Q1 2024 · Mar 31, 2023 | $2.33M |
| Stockholders Equity | Q1 2024 · Dec 31, 2022 | $2.44M |
| Eps Diluted | Q1 2024 · Mar 31, 2023 | $0.00 |
| Eps Basic | Q1 2024 · Mar 31, 2023 | $0.00 |
| Sga Expense | Q1 2024 · Mar 31, 2023 | $275.1K |
| Net Income | Q1 2024 · Mar 31, 2023 | −$110.6K |
| Operating Income | Q1 2024 · Mar 31, 2023 | −$154.31K |
| Cost Of Revenue | Q1 2024 · Mar 31, 2023 | $507.2K |
| Revenue | Q1 2024 · Mar 31, 2023 | $640.44K |